title: Reduction in urinary excretion of neutrophil gelatinase-associated lipocalin by angiotensin receptor blockers in hypertensive patients.
authors.forename: Masato
authors.initials: M
authors.lastname: Kasahara
authors.forename: Kiyoshi
authors.initials: K
authors.lastname: Mori
authors.forename: Noriko
authors.initials: N
authors.lastname: Satoh
authors.forename: Takashige
authors.initials: T
authors.lastname: Kuwabara
authors.forename: Hideki
authors.initials: H
authors.lastname: Yokoi
authors.forename: Akira
authors.initials: A
authors.lastname: Shimatsu
authors.forename: Akira
authors.initials: A
authors.lastname: Sugawara
authors.forename: Masashi
authors.initials: M
authors.lastname: Mukoyama
authors.forename: Kazuwa
authors.initials: K
authors.lastname: Nakao
mesh_terms: D000209:Acute-Phase Proteins / Q000652:urine*; D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use*; D057911:Angiotensin Receptor Antagonists; D003920:Diabetes Mellitus / Q000188:drug therapy* / Q000652:urine; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000652:urine; D007676:Kidney Failure, Chronic / Q000175:diagnosis*; D000071068:Lipocalin-2; D054834:Lipocalins / Q000652:urine*; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000188:drug therapy* / Q000652:urine; D011446:Prospective Studies; D011518:Proto-Oncogene Proteins / Q000652:urine*
chemical_list: D000209:Acute-Phase Proteins; D047228:Angiotensin II Type 1 Receptor Blockers; D057911:Angiotensin Receptor Antagonists; C489506:LCN2 protein, human; D000071068:Lipocalin-2; D054834:Lipocalins; D011518:Proto-Oncogene Proteins